Chapter 30 - Angiotensin-Converting Enzyme Inhibition
Review articleOpen access

AbstractAngiotensin-converting enzyme inhibitors slow the progression of left ventricular dysfunction in several clinical settings, and may protect cardiotoxicity induced by chemotherapy. There has been recent suggestions that there is a potential cardioprotective effect, especially with enalapril. Angiotensin II receptor blockers are a crucial drug in hypertension treatment, especially if there is any kind of intolerance to angiotensin-converting enzyme inhibitors. Its angiotensin-inhibiting effect may be protective.

Request full text

References (0)

Cited By (0)

No reference data.
No citation data.
Join Copernicus Academic and get access to over 12 million papers authored by 7+ million academics.
Join for free!